Can random bladder biopsies be eliminated after bacillus Calmette-Guérin therapy against carcinoma in situ?

Intravesical bacillus Calmette-Guérin (BCG) is the standard of care for bladder carcinoma in situ (CIS). The response to BCG therapy against CIS is generally assessed by random bladder biopsy (RBB).